You are here

Article info

Article menu
Download PDFPDF
Letter
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

Authors

  1. Professor P Cacoub, AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris, F-75013 France; patrice.cacoub{at}psl.aphp.fr
View Full Text

Citation

Delluc A, Limal N, Puéchal X, et al
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
Annals of the Rheumatic Diseases 2008;67:278-279.

Publication history

  • Accepted July 1, 2007
  • First published January 11, 2008.
Online issue publication 
December 29, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism